Human TREX1-KO Dual Reporter THP-1 Cells

NF-κB-SEAP & IRF-Lucia reporter monocytes

SPECIFICATIONS

Specifications

Target

TREX1

Target species

Human

Cell type
Monocytic
Growth properties
Suspension
Tissue origin
Human monocytes
Reporter gene
SEAP
Lucia®
Detection method
Colorimetric (SEAP), Bioluminescence (Lucia)
Growth medium

Complete RPMI 1640 (see TDS)

Antibiotic resistance
Blasticidin
Zeocin®
Mycoplasma-free

Verified using Plasmotest™

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    THP1-Dual™ KO-TREX1 Cells
  • Cat code: 
    thpd-kotrex
  • Quantity: 
    3-7 x 10^6 cells
Includes:
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Blasticidin (10 mg/ml)
  • 1 tube of QUANTI-Luc™ 4 Reagent (sufficient to prepare 25 ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution)

Shipping & Storage

  • Shipping method:  Dry ice
  • Storage:

    • Liquid nitrogen vapor
    Stability: 20 passages

    Caution:

    • Upon receipt, store immediately in liquid nitrogen vapor. Do not store cell vials at -80°C.

Details

TREX1 (also known as DNase III) is a major DNA-sensor nuclease in the cytoplasm.

The primary role of TREX1 is to target cellular DNA originating from aberrant replication and recombination [1]. TREX1 is bound to the ER (endoplasmic reticulum) and is able to degrade both single-stranded and double-stranded DNA as well as single-strand RNA. As a result, it blocks the activation of the cGAS-STING pathway, and thus dampening the nucleic acid sensor response. Therefore, it is thought to be a negative regulator of interferon (IFN) signaling preventing autoimmune diseases. Its acidic counterpart, DNase2, shares the same function, but is located in the lysosomes [2].

However,  TREX1 function also promotes protumor and -viral responses by degrading tumor- or virus-derived DNA that would otherwise stimulate the cGAS-STING pathway and elicit an immune response [2-3]. Unlike SAMHD1, another enzyme with nuclease activity, TREX1 boosts HIV-1 infection [4]. Mutations in TREX1 have been associated with a variety of disorders, such as the Aicardi–Goutières syndrome, Systemic Lupus Erythematosus or hereditary vascular retinopathy [1-4].

 

1. Kavanagh D. et al., 2008. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle. 7(12):1718-25.
2. Baris, Adrian M et al., 2021. “Nucleic Acid Sensing in the Tumor Vasculature.” Cancers vol. 13,17 4452.
3. Hemphill et al., 2021. TREX1 as a Novel Immunotherapeutic Target. Front Immunol. Apr 1;12:660184.
4. Hasan M. & Yan N., 2014. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases. Front Microbiol. 5:193 

DOCUMENTS

Documents

THP1-Dual™ KO-TREX1 Cells

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?